FDANot Yet Classified · Drug · FDA event 99860; recall number pending · Recalled October 14, 2026

Tri-Immune Boost (Glutathione recall — Centric Compounding LLC

Agency report date: October 14, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named: Tri-Immune Boost (Glutathione
Company / brand: Centric Compounding
Lot / serial / date codes: Lot #: 071626:B, Beyond Use Date: 8/30/26
Distribution: USA Nationwide.

Agency product description and boundaries

Tri-Immune Boost (Glutathione: 200 mg, Ascorbic Acid: 200 mg, Zinc: 2.5 mg), 30 mL vial, Rx only, Centric Compounding, 7447 Harwin Dr. Suite 111, Houston, TX 77036

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Affected product: Tri-Immune Boost (Glutathione recall status

3. Open the official notice or contact

View the official FDA enforcement record (openFDA) ↗

Official recall ID: Not yet assigned by the FDA — identified by FDA event ID 99860
Brand: All Centric Compounding recalls
Classification: Not Yet Classified
Units affected: N/A
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Affected products

Tri-Immune Boost (Glutathione recall status

Companies & origin

Recalling firm location: Tomball, TX, United States
Firm address: 909 Graham Dr Ste D, N/A, 77375-3335

Identifying details (verbatim from the notice)

Product codes / lots: Lot #: 071626:B, Beyond Use Date: 8/30/26
Distribution: USA Nationwide.
Firm notified the public via: E-Mail
FDA event ID: 99860
Recall initiated: July 27, 2026
FDA report date: October 14, 2026

Other drug recalls from around the same time

Thyroid Tablets recall — VITRUVIAS THERAPEUTICS INCFDA · September 23, 2026
0 recall — B BRAUN MEDICAL INCFDA · September 16, 2026
Epinephrine Injection recall — American Regent, Inc.FDA · September 16, 2026
Dextrose Injection recall — Baxter Healthcare CorporationFDA · September 16, 2026
Glutathione 200 mg/mL recall — OPTIMAL BALANCE PHARMACYFDA · September 9, 2026

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 12:00 PM UTC. Record retrieved October 22, 2026 at 12:00 PM UTC.

Report a data error on this page